Effects of intestinal flora on the metabolism and absorption of isoflavones

Japan Agricultural Research Quarterly

Volumn 40, Issue 1, 2006, Pages 45-50

  Tamura, Motoi ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Daidzein; Equol; Genistein

Indexed keywords

GLYCINE MAX;

EID: 33750015521     PISSN: 00213551     EISSN: 00213551     Source Type: Journal    
DOI: 10.6090/jarq.40.45     Document Type: Review

References (60)

1. Adlercreutz, H. et al. (1982) Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet, 320, 1295-1299.
2. Adlercreutz, H. et al. (1995) Soybean phytoestrogen intake and cancer risk. J. Nutr., 125, 757S-770S.
3. Akaza, H. et al. (2002) Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn. J. Clin. Oncol., 32, 296-300.
4. Andlauer, W., Kolb, J. & Fürst, P. (2000a) Absorption and metabolism of genistin in the isolated rat small intestine. FEBS Lett., 475, 127-130.
5. Andlauer, W., Kolb, J. & Fürst, P. (2000b) Isoflavones from tofu are absorbed and metabolized in the isolated rat small intestine. J. Nutr., 130, 3021-3027.
6. Andlauer, W. et al. (2000) Absorption and metabolism of genistein in isolated rat small intestine. J. Nutr., 130, 843-846.
7. Anthony, M. S. et al. (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler. Thromb. Vasc. Biol., 17, 2524-2531.
8. Bannwart, C. et al. (1984) o-Desmethylangolensin, a metabolite of daidzein and of matairesinol, one likely plant precursor of the animal lignan enterolactone in human urine. Finn. Chem. Lett., 4-5, 120-125.
9. Bowey, E., Adlercreutz, H. & Rowland, I. (2003) Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol., 41, 631-636.
10. Cassidy, A., Bingham, S. & Setchell, K. (1995) Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br. J. Nutr., 74, 587-601.
11. Clarkson, T. B. (2002) Soy, soy phytoestrogens and cardiovascular disease. J. Nutr., 132, 566S-569S.
12. Coward, L. et al. (1993) Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J. Agric. Food Chem., 41, 1961-1967.
13. Cruz, M. L. A. et al. (1994) Effects of infant nutrition on cholesterol synthesis rates. Pediatr. Res., 35, 135-140.
14. Duncan, A. M. et al. (2000) Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol. Biomarkers Preview, 9, 581-586.
15. Faughnan, M. S. et al. (2004) Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. Br. J. Nutr., 91, 567-574.
16. Fujiwara, S. (2002) Bifidobacterium longum SBT2928 and its biological significance. Biosci. Microflora, 21, 225-238.
17. Hur, H. -G. et al. (2000) Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch. Microbiol., 174, 422-428.
18. Hur, H. -G. & Rafii, F. (2000) Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum. FEMS Microbiol. Lett., 192, 21-25.
19. Hutchins, A. M., Slavin, J. L. & Lampe, J. W. (1995) Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J. Am. Diet. Assoc., 95, 545-551.
20. Izumi, T. et al. (2000) Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr., 130, 1695-1699.
21. Jenkins, D. J. A. et al. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr., 76, 365-372.
22. Joannou, G. E. et al. (1995) A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J. Steroid Biochem. Mol. Biol., 54, 167-184.
23. Kelly, G. E. et al. (1995) The variable metabolic response to dietary isoflavones in humans. Proc. Soc. Exp. Biol. Med., 208, 40-43.
24. King, R. A. & Bursill, D. B. (1998) Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr., 67, 867-872.
25. Lampe, J. W. et al. (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proc. Soc. Exp. Biol. Med., 217, 335-339.
26. Larsen, G. L. (1988) Deconjugation of biliary metabolites by microfloral β-glucuronidases, sulphatases and cysteine conjugate β-lyases and their subsequent enterohepatic circulation. In Role of the gut flora in toxicity and cancer, ed. Rowland, I. R., Academic Press, London, 79-107.
27. Lieberman, S. (1996) Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical? J. Clin. Endocrinol. Metab., 81, 850-851.
28. Meyer, B. J. et al. (2004) Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann. Nutr. Metab., 48, 67-78.
29. Mitchell, J. H. et al. (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Biochem. Biophys., 360, 142-148.
30. Morito, K. et al. (2001) Interaction of phytoestrogens with estrogen receptors α and β. Biol. Pharm. Bull., 24, 351-356.
31. Morton, M. S. et al. (2002) Phytoestrogen concentrations in serum from Japanese men and woman over forty years of age. J. Nutr., 132, 3168-3171.
32. Murphy, P. A. (1982) Phytoestrogen content of processed soybean products. Food Technol., 36(1), 60-64.
33. Ohta, A. et al. (2002) A combination of dietary fructo-oligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J. Nutr., 132, 2048-2054.
34. Potter, S. M. et al. (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr., 68, 1375S-1379S.
35. Richelle, M. et al. (2002) Hydrolysis of isoflavone glycosides to aglycones by β-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J. Nutr., 132, 2587-2592.
36. Rowland, I. R. et al. (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr. Cancer, 36, 27-32.
37. Schoefer, L. et al. (2002) Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol. Lett., 208, 197-202.
38. Setchell, K. D. R. (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr., 68, 1333S-1346S.
39. Setchell, K. D. R. & Adlercreutz, H. (1988) Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In Role of the gut flora in toxicity and cancer, ed. Rowland, I. R., Academic Press, London, 315-345.
40. Setchell, K. D. R. & Cassidy, A. (1999) Dietary isoflavones: biological effects and relevance to human health. J. Nutr., 129, 758S-767S.
41. Setchell, K. D. R. et al. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr., 40, 569-578.
42. Setchell, K. D. R. et al. (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet, 350, 23-27.
43. Setchell, K. D. R. et al. (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr., 131, 1362S-1375S.
44. Setchell, K. D. R. et al. (2002) Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr., 76, 447-453.
45. Setchell, K. D. R. et al. (2003) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr., 133,1027-1035.
46. Sfakianos, J. et al. (1997) Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr., 127, 1260-1268.
47. Shutt, D. A. & Cox, R. I. (1972) Steroid and phytooestrogen binding to sheep uterine receptors in vitro. J. Endocrinol., 52, 299-310.
48. Tamura, M., Hirayama, K. & Itoh, K. (1999) Effects of guar gum and cellulose on cecal enzyme activity and cecal short-chain fatty acids in young and aged mice. Ann. Nutr. Metab., 43, 60-65.
49. Tamura, M., Hirayama, K. & Itoh, K. (2003) Effects of soy oligosaccharides on plasma and cecal isoflavones, and cecal enzyme activities in mice. J. Nutr. Sci. Vitaminol., 49, 168-171.
50. Tamura, M., Ohnishi-Kameyama, M. & Shinohara, K. (2004) Lactobacillus gasseri: effects on mouse intestinal flora enzyme activity and isoflavonoids in the caecum and plasma. Br. J. Nutr., 92, 771-776.
51. Tamura, M. et al. (2002a) Effects of rice starch-isoflavone diet or potato starch-isoflavone diet on plasma isoflavone, plasma lipids, cecal enzyme activity, and composition of fecal microflora in adult mice. J. Nutr. Sci. Vitaminol., 48, 225-229.
52. Tamura, M. et al. (2002b) Effects of soy protein diet on plasma equol and intestinal microflora in adult mice. Biosci. Microflora, 21, 121-124.
53. Tamura, M. et al. (2002c) Effects of soy protein-isoflavone diet on plasma isoflavone and intestinal microflora in adult mice. Nutr. Res., 22, 705-713.
54. Tamura, M. et al. (2004) Effects of human intestinal flora on plasma and caecal isoflavones, and effects of isoflavones on the composition and metabolism of flora in human flora-associated (HFA) mice. Microbial. Ecol. Health Dis., 16, 18-22.
55. Tew, B. -Y. et al. (1996) A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women. J. Nutr., 126, 871-877.
56. Vedavanam, K. et al. (1999) Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother. Res., 13, 601-608.
57. Watanabe, S. et al. (1998) Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (Kinako). J. Nutr., 128, 1710-1715.
58. Xu, X. et al. (1995) Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr., 125, 2307-2315.
59. Zhuo, X. -G., Melby, M. K. & Watanabe, S. (2004) Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J. Nutr., 134, 2395-2400.
60. Zubik, L. & Meydani, M. (2003) Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr., 77, 1459-1465.